Medicilon

688202
74.520.40% ( +0.30 )
Delay Closed: Nov 17, 15:00:00

Valuation

Current ValuationThe current P/E ratio is -216.10, below the reasonable range, cheaper than 95.9% of the time in the past 3 years, and the industry ranks 27/27, the industry Median 46.32.

-216.1xP/E
Stock price¥74.22Earnings per share¥-0.34

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 46.32x
012243648

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 46.32x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
300347SZTigermed
-99.25x71.25%¥40.16B
688114SHMGI
-119.84x70.26%¥22.74B
688202SHMedicilon
-216.10x--¥9.97B
688068SHHotgen
-19.98x--¥5.98B
603108SHRunda Medical
-10.32x137.36%¥5.77B
300463SZmaccura
-158.72x133.73%¥5.22B
688238SHOBiO Tech
-19.17x18.92%¥4.20B
301096SZBio-S
-23.16x--¥4.13B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.